Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NONO | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | SACS | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | POSTN | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | ARL6IP5 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | STK17A | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | MRPL41 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | ZSCAN23 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | PRSS56 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | KDM6B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | BANK1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |